T cell receptor and immune gene expression pharmacodynamics for durvalumab monotherapy and in combination with tremelimumab or bevacizumab in unresectable hepatocellular carcinoma (uHCC).If you need further payment choices for Sparrow Ascent, you might take into account applying for Advance Care – the fastest and easiest way to pay for treatments